Data completeness
0/8 — Limited
Drug data last refreshed 17h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ACTIFED W/ CODEINE is an oral syrup combination product marketed by GSK containing a decongestant/antihistamine with codeine, a narcotic cough suppressant. The product is indicated for symptomatic relief of cough and cold symptoms in patients who require opioid-level cough suppression. It represents a small-molecule fixed-dose combination targeting upper respiratory symptom management.
Pre-Launch
Pre-launch stage offers opportunity to build brand infrastructure and develop go-to-market strategy, but team scaling will depend on regulatory approval timeline.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ACTIFED W/ CODEINE during pre-launch offers limited career visibility and hiring activity today, but positions early employees as foundational members of a new revenue stream if approval succeeds. Career growth depends heavily on regulatory success and post-launch market reception in a commoditized category with opioid headwinds.
Brand ManagerProduct Manager
Worked on ACTIFED W/ CODEINE at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.